Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03414619 · ClinicalTrials.gov registry record · NA
The Role of Cognitive Control in the Transdiagnostic Conceptualization of "Intrusive Thoughts"
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT03414619: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03414619 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03414619, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
The investigators are examining whether difficulties with cognitive control (i.e., the ability to stop one's thought process and shift attention) is a common problem across three types of repetitive, negative thinking: obsessions (as seen in obsessive compulsive disorder, OCD), worries (as seen in generalized anxiety disorder, GAD), and ruminations (as seen in major depressive disorder, MDD).
Interventions
- BEHAVIORAL Cognitive Control Tasks and Script Driven Imagery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2018-05-18 |
| Est. Completion | 2020-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03414619
The ClinicalTrials.gov registry entry for NCT03414619 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Control Tasks and Script Driven Imagery is the first listed.
NCT03414619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03414619 about?
NCT03414619 is a clinical study titled "The Role of Cognitive Control in the Transdiagnostic Conceptualization of "Intrusive Thoughts"". The investigators are examining whether difficulties with cognitive control (i.e., the ability to stop one's thought process and shift attention) is a common problem across three types of repetitive, negative thinking: obsessions (as seen in obsessive compulsive disorder, OCD), worries (as seen in g...
What is the current status of trial NCT03414619?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2018-05-18. Estimated completion is 2020-03-06.
What interventions are being tested in trial NCT03414619?
The interventions under investigation include: Cognitive Control Tasks and Script Driven Imagery (BEHAVIORAL).
Who is sponsoring clinical trial NCT03414619?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.